Chongqing Zhifei Biological Products Co Ltd
SZSE:300122

Watchlist Manager
Chongqing Zhifei Biological Products Co Ltd Logo
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Watchlist
Price: 27.62 CNY -1.92% Market Closed
Market Cap: 66.3B CNY
Have any thoughts about
Chongqing Zhifei Biological Products Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Chongqing Zhifei Biological Products Co Ltd

Wall Street analysts forecast Chongqing Zhifei Biological Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chongqing Zhifei Biological Products Co Ltd is 36.3 CNY with a low forecast of 25.31 CNY and a high forecast of 54.6 CNY.

Lowest
Price Target
25.31 CNY
8% Downside
Average
Price Target
36.3 CNY
31% Upside
Highest
Price Target
54.6 CNY
98% Upside
Chongqing Zhifei Biological Products Co Ltd Competitors:
Price Targets
MRKR
Marker Therapeutics Inc
323% Upside
4893
Noile-Immune Biotech Inc
181% Upside
KRRO
Korro Bio Inc
213% Upside
096530
Seegene Inc
65% Upside
GLUE
Monte Rosa Therapeutics Inc
142% Upside
LYEL
Lyell Immunopharma Inc
66% Upside
CDTX
Cidara Therapeutics Inc
34% Upside
MGX
Metagenomi Inc
363% Upside

Revenue
Forecast

Revenue Estimate
Chongqing Zhifei Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Chongqing Zhifei Biological Products Co Ltd's revenue is 71%. The projected CAGR for the next 3 years is -4%.

71%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Chongqing Zhifei Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Chongqing Zhifei Biological Products Co Ltd's operating income is 63%. The projected CAGR for the next 3 years is -4%.

63%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Chongqing Zhifei Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Chongqing Zhifei Biological Products Co Ltd's net income is 59%. The projected CAGR for the next 3 years is 2%.

59%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chongqing Zhifei Biological Products Co Ltd's stock price target?
Price Target
36.3 CNY

According to Wall Street analysts, the average 1-year price target for Chongqing Zhifei Biological Products Co Ltd is 36.3 CNY with a low forecast of 25.31 CNY and a high forecast of 54.6 CNY.

What is Chongqing Zhifei Biological Products Co Ltd's Revenue forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for Chongqing Zhifei Biological Products Co Ltd's revenue is 71%. The projected CAGR for the next 3 years is -4%.

What is Chongqing Zhifei Biological Products Co Ltd's Operating Income forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for Chongqing Zhifei Biological Products Co Ltd's operating income is 63%. The projected CAGR for the next 3 years is -4%.

What is Chongqing Zhifei Biological Products Co Ltd's Net Income forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Chongqing Zhifei Biological Products Co Ltd's net income is 59%. The projected CAGR for the next 3 years is 2%.

Back to Top